No Data
No Data
Vesicor Therapeutics to Go Public Via SPAC
Black Hawk Acquisition to Continue to Be Listed on Nasdaq, Change Name to Vesicor Therapeutics
Vesicor to Become Wholly Owned Subsidiary of Black Hawk
Express News | Black Hawk Acquisition Corp - Vesicor Valued at Pre-Money Equity Value of $70 Million
Press Release: Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter Into a Business Combination Agreement to Create a Biotechnology Company Advancing P53-based Cancer Therapeutics Delivered Via Microvesicles
Express News | Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter Into a Business Combination Agreement to Create a Biotechnology Company Advancing P53-Based Cancer Therapeutics Delivered via Microvesicles